These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
270 related items for PubMed ID: 21967031
21. Angiotensin-II receptor antagonist combined with calcium channel blocker or diuretic for essential hypertension. Ishimitsu T, Numabe A, Masuda T, Akabane T, Okamura A, Minami J, Matsuoka H. Hypertens Res; 2009 Nov; 32(11):962-8. PubMed ID: 19696778 [Abstract] [Full Text] [Related]
22. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril. Middeke M, Richter WO, Schwandt P, Holzgreve H. Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337 [Abstract] [Full Text] [Related]
23. Effect of antihypertensive treatment on microvascular structure, central blood pressure and oxidative stress in patients with mild essential hypertension. De Ciuceis C, Salvetti M, Rossini C, Muiesan ML, Paini A, Duse S, La Boria E, Semeraro F, Cancarini A, Rosei CA, Sarkar A, Ruggeri G, Caimi L, Ricotta D, Rizzoni D, Rosei EA. J Hypertens; 2014 Mar; 32(3):565-74. PubMed ID: 24378999 [Abstract] [Full Text] [Related]
24. Lercanidipine in patients with chronic renal failure: the ZAFRA study. Robles NR, Ocon J, Gomez CF, Manjon M, Pastor L, Herrera J, Villatoro J, Calls J, Torrijos J, Rodríguez VI, Rodriguez MM, Mendez ML, Morey A, Martinez FI, Marco J, Liebana A, Rincon B, Tornero F. Ren Fail; 2005 Mar; 27(1):73-80. PubMed ID: 15717638 [Abstract] [Full Text] [Related]
25. Drug synergism of antihypertensive action in combination of telmisartan with lercanidipine in spontaneous hypertensive rats. Lee JJ, Shin CY, Park HJ, Zhang WY, Kim Y, Kim IS, Lee KH, Myung CS. Arch Pharm Res; 2010 Sep; 33(9):1411-8. PubMed ID: 20945140 [Abstract] [Full Text] [Related]
26. [Treatment for the elderly hypertensive patient with renal insufficiency]. Kobayashi K, Kanno Y, Suzuki H. Nihon Rinsho; 2005 Jun; 63(6):1047-51. PubMed ID: 15948389 [Abstract] [Full Text] [Related]
27. Effect of antihypertensive agents on plasma adiponectin levels in hypertensive patients with metabolic syndrome. Yilmaz MI, Sonmez A, Caglar K, Celik T, Yenicesu M, Eyileten T, Acikel C, Oguz Y, Yavuz I, Vural A. Nephrology (Carlton); 2007 Apr; 12(2):147-53. PubMed ID: 17371337 [Abstract] [Full Text] [Related]
28. Effect of lercanidipine compared with ramipril on albumin excretion rate in hypertensive Type 2 diabetic patients with microalbuminuria: DIAL study (diabete, ipertensione, albuminuria, lercanidipina). Dalla Vestra M, Pozza G, Mosca A, Grazioli V, Lapolla A, Fioretto P, Crepaldi G. Diabetes Nutr Metab; 2004 Oct; 17(5):259-66. PubMed ID: 16295047 [Abstract] [Full Text] [Related]
29. Differential impact of angiotensin receptor blockers and calcium channel blockers on arterial stiffness. Andreadis EA, Sfakianakis ME, Tsourous GI, Georgiopoulos DX, Fragouli EG, Katsanou PM, Tavoularis EI, Skarlatou MG, Marakomichelakis GE, Ifanti GK, Diamantopoulos EJ. Int Angiol; 2010 Jun; 29(3):266-72. PubMed ID: 20502415 [Abstract] [Full Text] [Related]
30. [Antihypertensive therapy for refractory morning hypertension in patients on peritoneal dialysis]. Kuriyama S, Otsuka Y, Iida R, Kobayashi S, Yamagishi H, Hosoya T. Nihon Jinzo Gakkai Shi; 2005 Jun; 47(1):38-45. PubMed ID: 15754762 [Abstract] [Full Text] [Related]
31. In half of hypertensive diabetics, co-administration of a calcium channel blocker and an angiotensin-converting enzyme inhibitor achieved a target blood pressure of <130/80 mmHg: the azelnidipine and temocapril in hypertensive patients with type 2 diabetes (ATTEST) study. Katayama S, Kawamori R, Iwamoto Y, Saito I, Kuramoto K, ATTEST Study Group. Hypertens Res; 2008 Aug; 31(8):1499-508. PubMed ID: 18971523 [Abstract] [Full Text] [Related]
32. Retrospective analysis of real-world efficacy of angiotensin receptor blockers versus other classes of antihypertensive agents in blood pressure management. Petrella R, Michailidis P. Clin Ther; 2011 Sep; 33(9):1190-203. PubMed ID: 21885126 [Abstract] [Full Text] [Related]
33. Effects of enalapril/lercanidipine combination on some emerging biomarkers in cardiovascular risk stratification in hypertensive patients. Derosa G, Bonaventura A, Romano D, Bianchi L, Fogari E, D'Angelo A, Maffioli P. J Clin Pharm Ther; 2014 Jun; 39(3):277-85. PubMed ID: 24635387 [Abstract] [Full Text] [Related]
34. Combination therapy with lercanidipine and enalapril in the management of the hypertensive patient: an update of the evidence. Antza C, Stabouli S, Kotsis V. Vasc Health Risk Manag; 2016 Jun; 12():443-451. PubMed ID: 27895487 [Abstract] [Full Text] [Related]
35. Additional antihypertensive effect of drugs in hypertensive subjects uncontrolled on diltiazem monotherapy: a randomized controlled trial using office and home blood pressure monitoring. Karotsis AK, Symeonidis A, Mastorantonakis SE, Stergiou GS, Home-Di-Plus Study Group. Clin Exp Hypertens; 2006 Oct; 28(7):655-62. PubMed ID: 17060064 [Abstract] [Full Text] [Related]
36. [Effect of Fixed Lercanidipine/Enalapril Combination on 24-Hour Blood Pressure Proffie in Elderly Patients With Arterial Hypertension]. Gosteva EV, Vasil'eva LV. Kardiologiia; 2015 Oct; 55(2):32-6. PubMed ID: 26164986 [Abstract] [Full Text] [Related]
37. [Effectiveness and tolerance of fosinopril in the treatment of arterial hypertension of mild and medium severity]. Rosolová H, Cech J, Sefrna F. Vnitr Lek; 2001 Dec; 47(12):834-9. PubMed ID: 11826546 [Abstract] [Full Text] [Related]
38. [Evaluation of lercanidipine in the general practice setting]. Robles NR, Canelada JA, Iglesias M, Angulo E, López Acedo A, Díaz Olea E, Cidoncha F, Guerras M, Fuentes J, Garrido J, Lapie J, Peña J, Aguilar A, Hidalgo P. An Med Interna; 2003 Jun; 20(6):282-6. PubMed ID: 12848597 [Abstract] [Full Text] [Related]
39. Blood pressure and serum potassium levels in hypertensive patients receiving or not receiving antihypertensive treatment. Pikilidou MI, Lasaridis AN, Sarafidis PA, Tziolas IM, Zebekakis PE, Dombros NV, Giannoulis E. Clin Exp Hypertens; 2007 Nov; 29(8):563-73. PubMed ID: 18058481 [Abstract] [Full Text] [Related]
40. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy. Khan NA, McAlister FA, Campbell NR, Feldman RD, Rabkin S, Mahon J, Lewanczuk R, Zarnke KB, Hemmelgarn B, Lebel M, Levine M, Herbert C, Canadian Hypertension Education Program. Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]